Alison M. Luckey
Geneve, GE 1202, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Zoliflodacin: non-inferior, but not equivalent? - Authors' reply.
Journal: Lancet (London, England)
Published: March 27, 2026
Evaluation of Drug-Drug Interaction Potential Between the Oral Antibiotic Zoliflodacin and the CYP3A4 Inhibitor Itraconazole: A Phase 1 Study in Healthy Participants.
Journal: Clinical and translational science
Published: November 28, 2025
Microbiological analysis and whole-genome sequencing of Neisseria gonorrhoeae from the microbiological failures in the international, zoliflodacin, phase 3, clinical trial for treatment of uncomplicated urogenital gonorrhoea: a retrospective, genomic, observational study.
Journal: The Lancet. Microbe
Published: June 24, 2025
Zoliflodacin versus ceftriaxone plus azithromycin for treatment of uncomplicated urogenital gonorrhoea: an international, randomised, controlled, open-label, phase 3, non-inferiority clinical trial.
Journal: Lancet (London, England)
Published: June 09, 2025
Letter to the editor regarding "Alternative drugs for the treatment of gonococcal infections: old and new" Expert Review of Anti-infective Therapy. 2024. 22(9):753-759.
Journal: Expert review of anti-infective therapy
Published: May 05, 2025
Aztreonam-avibactam versus meropenem for the treatment of serious infections caused by Gram-negative bacteria (REVISIT): a descriptive, multinational, open-label, phase 3, randomised trial.
Journal: The Lancet. Infectious diseases
Published: April 17, 2024
Recommendations for the optimal introduction of novel antibiotics to treat uncomplicated gonorrhoea in the face of increasing antimicrobial resistance: a case study with zoliflodacin.
Journal: BMC global and public health
Published: April 16, 2024
Dose selection for aztreonam-avibactam, including adjustments for renal impairment, for Phase IIa and Phase III evaluation.
Journal: European journal of clinical pharmacology
Published: December 22, 2022
Effect of food on the pharmacokinetics of zoliflodacin granules for oral suspension: Phase I open-label randomized cross-over study in healthy subjects.
Journal: Clinical and translational science
Published: September 08, 2022
Factors associated with recruitment success in the phase 2a study of aztreonam-avibactam development programme: a descriptive qualitative analysis among sites in Spain.
Journal: BMJ open
Published: February 04, 2022
Pharmacokinetics and safety of aztreonam/avibactam for the treatment of complicated intra-abdominal infections in hospitalized adults: results from the REJUVENATE study.
Journal: The Journal of antimicrobial chemotherapy
Published: July 18, 2019
Safety, tolerability and pharmacodynamics of a novel immunomodulator, MIS416, in patients with chronic progressive multiple sclerosis.
Journal: Multiple sclerosis journal - experimental, translational and clinical
Published: October 21, 2014
Showing 1-12 of 12
Last Updated: 09/26/2026